Jul 27, 2009 · We studied GVHD after donor lymphocyte infusion (DLI) in 328 patients with relapsed CML between 1991 and 2004. A total of 122 patients (38%) developed some ...
Jul 27, 2009 · The goal of this study was to describe in detail GVHD occurring after DLI with a focus on clinical presentation, time of onset, organ involvement, severity, ...
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Y. Chalandon, J. R. ...
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT. Y. Chalandon, J. R. ...
Nov 16, 2005 · Using data submitted to the EBMT registry, we analyzed outcome on 344 patients (pts) who had received donor lymphocyte infusions (DLI) for ...
People also ask
What is the life expectancy of someone with chronic GVHD?
What are the odds of surviving GVHD?
What is the prognosis for GVHD?
What is the death rate of GVHD?
DLI is more effective in chronic myeloid leukemia (CML), leading to complete remission (CR) in 70-80% of patients in hematologic or cytogenetic CML relapse, ...
We studied GVHD after donor lymphocyte infusion (DLI) in 328 patients with relapsed CML between 1991 and 2004 . A total of 122 patients (38%) developed some ...
Outcome of patients devel- · oping GVHD after DLI given to treat CML relapse: a study by the · Chronic Leukemia Working Party of the EBMT. Bone Marrow ...
[10] reported a cohort of patients receiving DLI in which initial doses of >1 × 108 cells/kg were associated with higher GvHD and did not improved relapse risk ...
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT. Outcome of patients ...